Pinealon
Also known as: Glu-Asp-Arg, EDR peptide
Synthetic Glu-Asp-Arg tripeptide bioregulator for neuroprotection, memory and focus; it crosses the blood-brain barrier and modulates gene expression. Run in 10-20 day cycles with 2-3 months off to avoid receptor desensitisation, dosed in the morning. SubQ or intranasal is preferred since oral efficacy is debated.
Pharmacokinetics
- Half-life
- 30 min
- Time to peak
- 15 min
- Bioavailability
- 80%
- Dosing interval
- 24h
Administration
- Primary routes
- SubQ, Intranasal, Oral
- Category
- Neurological
Safety Flags
No registry-level safety flags. Always check drug-peptide interactions for your specific stack in the Lab.
Storage
- · Requires refrigeration (2–8°C)
- · Temperature sensitive — minimise room-temp exposure
Used in 3 outcome protocols
- NeuroprotectionPrimary
Protect and regenerate neural tissue for brain health
Safe default: 150mcg · daily (10-20 day cycle) · SubQ
- Memory Management
Enhance cognitive function and memory formation
Safe default: 150mcg · daily (10-20 day cycle) · SubQ
- Focus / ADHD
Improve attention, focus, and cognitive clarity
Safe default: 150mcg · daily (10-20 day cycle) · SubQ
Simulate Pinealon
Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.